Ownership history in BARCLAYS PLC · 9 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in ESSA PHARMA INC (EPIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 355 | — | 0% | 0.00% | $68 | — |
| 2025 Q2 | UNCHANGED | 355 | — | 0% | 0.00% | $1K | — |
| 2025 Q1 | UNCHANGED | 355 | — | 0% | 0.00% | $1K | — |
| 2024 Q4 | UNCHANGED | 355 | — | 0% | 0.00% | $1K | — |
| 2024 Q3 | REDUCED | 355 | -616 | -63.4% | 0.00% | $2K | — |
| 2023 Q4 | REDUCED | 971 | -317 | -24.6% | 0.00% | $6K | — |
| 2023 Q3 | ADDED | 1,288 | +1,176 | +1050.0% | 0.00% | $4K | — |
| 2022 Q1 | REDUCED | 112 | -77,188 | -99.9% | 0.00% | $1K | — |
| 2021 Q3 | INITIATED | 77,300 | — | — | 0.00% | $618K | — |
As of 2025 Q3 — sorted by position size